Delivery Order SPE2DB24D2010-SPE2DB24FZXB4

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FRQ48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,122.36 and is a Firm Fixed Price Delivery Order type, with an ultimate completion date of August 28, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office Division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical product. The contract has a Firm Fixed Price pricing type and a ceiling value of $4,808.20. It is a Delivery Order contract with a performance period ending on July 22, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of November 14, 2024 and a ceiling value of $4,278.71. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF8T1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $3,441.70. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, SPE2DB24D1104|SPE2DB25FXTM7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,106.18, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB25FAJ00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $30,766.32 and a completion date of November 7, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The award has a ceiling value of $5,041.77 and a completion date of September 11, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any special designation. Amerisourcebergen has been awarded multiple federal contracts and...
This federal contract award with ID SPE2DB22D1017|SPE2DB24FF7QW was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $8,498.86, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 15, 2024. This...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT7T8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $7,514.04 and an ultimate completion date of January 13, 2025. This award is not...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $4,671.60 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 23, 2022. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor,...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZXB4
    Delivery Order

This federal contract award, with an ID of SPE2DB24D2010|SPE2DB24FZXB4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,389.91 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of August 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to supply the DLA with the specified pharmaceutical product, which is likely used to support various military healthcare programs and facilities. The company has a history of providing a wide range of medical commodities, including prescription medications, medical supplies, and equipment, to federal agencies through its extensive supply chain and distribution capabilities.

Generated 11/15/24, 9:14 AM